For Providers

How has Allergychoices helped your practice, and patients, with allergy drop treatment?

"Since 60% of our sinus patients, at least, have allergies, they do so much better after surgery, they feel better, they need less medication."

Provider review

Watch the review

Reviewed by

— Michelle Leonard, DNP, CT ENT Sinus Center

In their own words

“Our ENT surgeon has a large sinus surgery practice. We also treat our sinus patients medically. We weren’t treating the whole patient before we added this to what we do. Since 60% of our sinus patients, at least, have allergies, they do so much better after surgery, they feel better, they need less medication. So it has helped our practice immensely and the patients are happy they don’t have go anywhere else; they want to stay with us. They can do everything under one roof. It’s a win-win for everybody.”

Keep watching

More provider reviews

Next step

Tired of seeing your allergy patients suffer?

Call us at (866) 793-1680 or fill out this form to discuss offering this safe and effective option!

Regulatory status of allergy drops

A small number of sublingual immunotherapy (SLIT) tablets are FDA-approved for specific allergens. Personalized allergy drops are compounded by a pharmacy for each patient and prescribed off-label — a long-standing, legitimate practice with decades of use, and SLIT is a first-line prescription approach in much of Europe. Compounded allergy drops are not FDA-approved, but they are created using FDA-approved allergenic extracts, the same as in allergy shots. Off-label does not mean unsafe or experimental.

U.S. allergenic extracts are licensed and labeled for injection and skin testing, not for the sublingual route, so prescribing them as sublingual drops is an off-label clinical decision made by the treating provider.